View Article

  • Method Development and Validation of Desidustat in Solid Dosage Form by RP-HPLC Method

  • Department of pharmacognocy, Matoshri College of Pharmacy, Eklhare Nashik.

Abstract

Desidustat is a novel oral hypoxia-inducible factor prolyl hydroxylase (HIF-PH) inhibitor used for the treatment of anemia associated with chronic kidney disease. It acts by stabilizing hypoxia-inducible factors, thereby stimulating endogenous erythropoietin production and improving iron metabolism. A new simple, precise, accurate, sensitive, and rapid RP-HPLC method was developed and validated for the estimation of Desidustat in pharmaceutical solid dosage form. Desidustat was chromatographed on an Inertsil ODS-3V, 150 mm × 4.6 mm ID, 5 µm column using a mobile phase consisting of Acetonitrile:Water (75:25, v/v) under isocratic conditions. The mobile phase was pumped at a flow rate of 1.0 mL/min and the analyte was detected at 232 nm using a UV detector. The retention time of Desidustat was satisfactory with good peak symmetry. The detector response was linear in the concentration range of 10–50 µg/mL with a correlation coefficient greater than 0.999. The developed method was validated according to ICH Q2(R1) guidelines for accuracy, precision, linearity, specificity, robustness, limit of detection, and limit of quantification. The intra-day and inter-day precision studies showed %RSD values less than 2.0%, indicating good precision of the method. The percentage recovery of the drug was within acceptable limits, confirming the accuracy of the proposed method. The developed RP-HPLC method was found to be simple, economical, reproducible, and suitable for routine quantitative analysis of Desidustat in tablet dosage forms in quality control laboratories

Keywords

Desidustat, RP-HPLC, accuracy, precision, validation

Introduction

× Popup Image

The development of sound analytical methods is of supreme importance during the process of drug discovery, product release, and development, culminating in marketing approval. The objective of analytical method development is to optimize and validate a method for the drug product from the developmental stage of the formulation. Validation demonstrates that processes involved in drug development, production, and analytical testing can be performed in an effective and reproducible manner (1,2).

High Performance Liquid Chromatography (HPLC) is one of the most widely used analytical techniques. Chromatography is a separation technique involving mass transfer between stationary and mobile phases. In HPLC, a liquid mobile phase is used to separate the components of a mixture as they pass through a packed column under high pressure. Separation depends on differences in interaction between analytes and the stationary phase. By choosing suitable mobile and stationary phases, HPLC can separate a wide variety of compounds with high versatility and reliability (3,4).

Desidustat is a novel oral hypoxia-inducible factor prolyl hydroxylase inhibitor used for the treatment of anemia associated with chronic kidney disease. It works by stabilizing hypoxia-inducible factors, stimulating endogenous erythropoietin production, and improving iron metabolism. Because only limited analytical methods were available for this drug, there was a need for a simple, rapid, and validated RP-HPLC method suitable for routine pharmaceutical analysis (5,6).

The present study was designed to develop and validate an RP-HPLC method for Desidustat in solid dosage form according to ICH guidelines (1).

MATERIALS AND METHODS

Materials 

Desidustat reference standard and marketed tablet formulation were used in the study. The marketed product mentioned in the thesis is Rystat 100 tablet. HPLC-grade acetonitrile, water, and other reagents used in the study were of analytical or chromatographic grade.  

Instrumentation 

Chromatographic analysis was carried out using an HPLC system equipped with UV detection. The column used was Inertsil ODS-3V, 150 mm × 4.6 mm ID, 5 µm. The detection wavelength selected for analysis was 232 nm.  

Chromatographic Conditions 

The optimized chromatographic conditions were: 

•      Column: Inertsil ODS-3V, 150 mm × 4.6 mm, 5 µm.  

•      Mobile phase: Acetonitrile:Water (75:25, v/v).  

•      Mode: Isocratic.  

•      Flow rate: 1.0 mL/min.  

•      Detection wavelength: 232 nm.  

•      Retention time: approximately 2.63 min.  

•      Run time: approximately 9 min. 

Placebo preparation:  

 

Sr. No.

Ingredients

Role

Qty (mg)

1

Lactose

Filler

80

2

Starch

Binder

5

3

Magnesium stearate

Lubricant

5

4

Talc

Glidant

5

5

crospovidone

Disintegrants

5

 

Total

 

100 mg

 

Method Development 

Different trial chromatographic conditions were evaluated to obtain a sharp, symmetrical peak with acceptable system suitability parameters. The final conditions were selected based on retention time, peak shape, resolution, and reproducibility. The method was then optimized for routine assay of Desidustat in tablet dosage form.  

Method Validation 

The method was validated according to ICH Q2(R1) guidelines for the following parameters: 

•      Specificity.  

•      Linearity.  

•      Range.  

•      Accuracy.  

•      Precision.  

•      Limit of detection.  

•      Limit of quantitation.  

•      Robustness.  

•      System suitability. 

LINEARITY AND RANGE: 

  

 

Sr. No.

Level

(%)

mL of stock solution

Diluted to with

Mobile phase (mL)

Desidustat

Concentration (µg/mL)

1

50%

1.0

10

5.00

2

75%

1.5

10

7.50

3

100%

2.0

10

10.00

4

125%

2.5

10

12.50

5

150%

3.0

10

15.00

 

Accuracy levels details:  

Refer Following table for each sample:  

 

  Level  

(%)   

API  

(mg)   

Placebo   

Diluted to

(mL)   

            Volume

taken(mL)

Diluted to  

(mL)   

Conc  

(µg/mL)   

50  

50.10  

202.6  

100  

0.2  

20  

5.01  

50.20  

202.4  

100  

0.2  

20  

5.02  

49.90  

202.3  

100  

0.2  

20  

4.99  

100  

100.00  

202.1  

100  

0.2  

20  

10.00  

100.20  

203.1  

100  

0.2  

20  

10.02  

 

100.50  

204.2  

100  

0.2  

20  

10.05  

150  

150.10  

202.5  

100  

0.2  

20  

15.01  

149.80  

201.8  

100  

0.2  

20  

14.98  

150.00  

203.2  

100  

0.2  

20  

15.00  

 

Precision (Repeatability) Sample details are as follows:  

 

Sample

Powder wt

(mg)

Diluted to (mL)

Volume taken

(mL)

Diluted to (mL)

Sample 1

301.6

100

0.2

20

Sample 2

302.5

100

0.2

20

Sample 3

301.9

100

0.2

20

Sample 4

303.2

100

0.2

20

Sample 5

302.5

100

0.2

20

Sample 6

302.8

100

0.2

20

 

Intermediate Precision Sample details are as follows:  

 

Sample

Powder wt. (mg)

Diluted to (mL)

Volume taken

(mL)

Diluted to

(mL)

Sample 1

301.6

7026532

97.15

301.6

Sample 2

302.5

7115290

98.08

302.5

Sample 3

301.9

7095268

98.00

301.9

Sample 4

303.2

7142518

98.23

303.2

Sample 5

302.5

7095237

97.80

302.5

Sample 6

302.8

7056238

97.17

302.8

 

Sample Preparation 

Tablet samples were prepared according to the procedure described in the thesis. The sample solution was filtered and analyzed under the optimized chromatographic conditions. Placebo and blank solutions were also prepared for specificity assessment.  

 RESULTS System Suitability 

The system suitability parameters met the acceptance criteria. The method provided a satisfactory retention time, good peak symmetry, and acceptable chromatographic performance for routine analysis. The thesis acceptance limits for system suitability included theoretical plates greater than 2000, capacity factor less than 1, resolution greater than 1.5, tailing factor less than 2, and %RSD less than 2.  

Specificity 

Blank and placebo chromatograms showed no interference at the retention time of Desidustat, demonstrating the specificity of the method. The analyte peak was well resolved and free from co-eluting peaks.  

Linearity 

The detector response was linear in the concentration range of 10–50 µg/mL. The calibration curve showed a correlation coefficient greater than 0.999, indicating excellent linearity.  

Accuracy 

Accuracy was evaluated at 50%, 100%, and 150% levels. The percentage recovery values were within acceptable limits, confirming that the method is accurate for tablet analysis.  

Precision 

Repeatability, intra-day precision, and inter-day precision studies showed %RSD values below 2.0%, indicating that the method is precise and reproducible.  

Robustness 

The method remained unaffected by small deliberate variations in flow rate, mobile phase composition, and temperature, demonstrating robustness.  

 

Assay 

The assay of the marketed tablet formulation showed satisfactory recovery and confirmed the suitability of the proposed method for routine quality control analysis.  

Solubility study Desidustat  

 

Sr. No.

Name of   

Solvent   

Observation   

Conclusion   

Summary   

1  

Water  

Drug Particles seen after sonication  

Drug was not found soluble in water.  

DMSO used as  a diluent for  

preparing stock

 

 

 

 

2  

Methanol  

Drug Particles seen after sonication  

Drug was not found soluble in methanol.  

solution.  

3  

Ethanol  

Drug Particles seen after sonication  

Drug was not found soluble in Ethanol.  

4  

Acetonitrile  

Drug Particles seen after sonication  

Drug was not found soluble in Acetonitrile  

5  

0.1 N HCl  

 Drug Particles seen after sonication  

Drug was not found soluble in 0.1 N HCl.  

6  

0.1 N NaOH 

 Drug Particles seen after sonication  

Drug was not found soluble in 0.1 N NaOH   

7  

DMSO  

No Drug Particles seen after sonication  

Drug was found soluble in  DMSO.  

Fig.  UV spectrum of Solution 1 as blank

 

 

 

 

 

 

Fig. Typical chromatogram of Trial 1

 

 

 

Fig. Typical chromatogram of Trial 2  Trial

3:

 

 

Fig. Typical chromatogram of Trial 3  Trial

4:

 

 

 

  

Fig. Typical chromatogram of Trial 4  Conclusion: From the observations of trials first to four, it was concluded that chromatographic conditions in trial four gives better peak, good retention time and tailing factor therefore chromatographic conditions in trial four was used for method validation   Table. Optimized Chromatographic Conditions  

 

Parameter

Description

Mode

Isocratic

Column Name

Inertsil ODS-3V, 150 mm X 4.6mm ID, 5μm

Detector

UV Detector

Injection Volume

20 µl

Wavelength

232 nm

Column Oven temp

40ºC

Mobile Phase

Acetonitrile :Water (75:25 %V/V)

Flow Rate

1.0 ml/min

Diluent

Stock solution: DMSO followed by methanol

Final dilution: Mobile phase

Run time

6 Minutes

 

8.4. System suitability test  

 

Sr No.

Standard solution

Area

Asymmetry

Theoretical plates

1

Standard_1

7256521

1.32

6240

2

Standard_2

7249562

1.32

6249

3

Standard_3

7244851

1.32

6251

4

Standard_4

7259532

1.31

6243

5

Standard_5

7250268

1.32

6261

 

Mean

7252147

1.32

6249

STD Dev

5854.797

 

% RSD

0.08

 

 

 

Fig. Typical chromatogram Standard solution 1 of system suitability solution

 

 

 

Analysis of Marketed Test samples (Assay)  

a) Rytstat100mg Tablet: Weight of 20 tablets = 6.0480gm  

Average weight of tablet = 6.0480 /20 =0.3024gm = 302.4mg 

 

 

Table. Assay results of Rytstat 100Tablet

Sample

Area

% Assay

Assay

Sample 1

7115821

98.06

98.42

Sample 2

7156532

98.78

 

Fig. Typical chromatogram Tablet sample_1  

1) % Assay found should be in the range of 90-110%.  

Data interpretation:   

From the above results, it can be concluded that the assay result is within the limit for selected marketed test sample and sample can be used for validation.  

8.6. VALIDATION OF RP-HPLC METHOD  1) FILTRATION STUDY:  

Filtration study of an analytical procedure checks the interference of extraneous components from filter, deposition on filter bed and compatibility of filter with sample. Performed on tablet test sample.  

 

Table. Results of Filter study

Sample description

Area

% Absolute difference

Unfiltered

7169532

NA

0.45 µ PVDF filter

7123568

0.64

0.45 µ Nylon filter

7145829

0.33

 

 

 

Fig.No. Typical chromatogram of unfiltered sample

Fig. Typical chromatogram of sample filtered through 0.45µ PVDF filter

 

 

Fig. Typical chromatogram of sample filtered through 0.45µ Nylon filter Acceptance criteria:% Absolute difference of filtered samples NMT 2.0 w.r.t. Unfiltered sample.

 

Table. Results of Solution stability

 

le solution

 

 

ard solution

 

point

 

solute differen

cpoint

 

solute differenc

 

60

 

 

24

 

urs

29

 

urs

09

 

urs

51

 

urs

53

 

 

 

 

Fig. Typical chromatogram of Standard solution Initial

 

 

Fig. Typical chromatogram of Test solution After 24 Hrs

 

Table. Results of Specificity

Description

Observation

Bank

o interference at R.T. of Desidustat due to blank

pacebo

o interference at R.T. of Desidustat due to placebo

 

 Chromatograms:   

 

 

  

 

 

 

 

 

Fig. Typical chromatogram of Placebo solution Acceptance criteria:

 

Blank: There should be no Interference at R.T. of Desidustat  

Placebo: There should be no Interference at R.T. of Desidustat  

Data interpretation: Blank and placebo were not having interference at R.T. of Desidustat. Hence developed chromatographic method passed the criteria for specificity. 

 

Table. Linearity Data for Desidustat

 

Level

Conc (µg/mL)

Area

Mean

% RSD

50%

5.00

3636532

3639304

0.068

3640129

3641251

75%

7.50

5469539

5473308

0.108

5480126

5470259

100%

10.00

7265239

7255977

0.190

7240152

7262539

125%

12.50

9023561

9038742

0.151

9050129

9042535

150%

15.00

10823561

10830526

0.094

10842153  

10825865  

 

 

 

 

 

Fig. Calibration curve of Desidustat

 

Table. Data of linearity of  Desidustat:

Sr no.

Parameter

Result value

Acceptance criteria

1

Beer's linearity range

5.00-15.00 µg/mL

NA

2

Correlation coefficient (R2)

0.99999

NLT 0.98

3

Intercept

68420.20

To be report

4

Slope

717915.12

To be report

5

% RSD for area at each level

NA

NMT 2.0

 

Fig. Typical chromatogram of Linearity 50%

 

 

 

Fig. No. 47 Typical chromatogram of Linearity 100%

 

 

 

Fig.  Typical chromatogram of Linearity 150% Conclusion:

 

From the calibration curve it was concluded that the Desidustat shows linear response in the range of 5.0015.00μg/ml. The Regression value was found well within the limit.  

 Limit of Detection (LOD) and Limit of Quantitation (LOQ):  

σ = 14985.08 (Residual standard deviation of a regression line)  

S = 717915.12(Slope)  

Detection limit (LOD):  

LOD = 3.3 σ / S  

LOD = 3.3 x 14985.08/ 717915.12  

LOD = 0.07µg/mL  

Quantitation limit (LOQ):  

LOQ = 10 σ / S  

LOQ = 10 x 14985.08/ 717915.12  

LOQ = 0.21µg/mL  

 ACCURACY (RECOVERY):  

 

Table. Result and statistical data of Accuracy of Desidustat

 

Level

(%)

Area

Recovered conc

(µg/mL)

Added

conc

(µg/mL)

%

Recovery

Mean

Recovery

% RSD

50

3645109

5.03

5.01

100.40

100.13

0.461

3652109

5.04

5.02

100.40

3605231

4.97

4.99

99.60

100

7256204

10.01

10.00

100.10

100.33

0.492

7269568

10.02

10.02

100.00

7350256

10.14

10.05

100.90

150

10850268

14.96

15.01

99.67

100.42

0.728

10913562

15.05

14.98

100.47

11000135

15.17

15.00

101.13

Overall Recovery: 100.30 %

 

% RSD for Overall Recovery: 0.513  

 

 

 

Fig.  Typical chromatogram of sample 1 of Accuracy 50%

 

 

 

Fig. Typical chromatogram of sample 1 of Accuracy 100%

 

Fig. Typical chromatogram of sample 1 of Accuracy 150% Acceptance criteria:

 

% Recovery for each level and overall recovery: 98.0 to 102.0%  

% RSD for each level and overall recovery: NMT 2.0  

Data interpretation: Recovery of analytical procedure was found well within acceptance criteria at all 3 levels. % Recovery not get hampered by changed in analyte concentration.  

 PRECISION   

Precision of an analytical method is the degree of agreement among individual test results when the procedure is applied repeatedly to multiple samplings of a homogenous sample. Precision of an analytical method is usually expressed as standard deviation or relative standard deviation. Precision was performed on Test sample.   

 

Table No.Result of Intra- day and Inter- Day Precision for Desidustat test sample   

 

Repeatability

Sample

Test Sample  (mg)

Area

% Assay

Sample 1

301.6

7026532

97.15

Sample 2

302.5

7115290

98.08

Sample 3

301.9

7095268

98.00

 

Sample 4

303.2

7142518

98.23

 

Sample 5

302.5

7095237

97.80

Sample 6

302.8

7056238

97.17

 

Mean

 

97.74

 

STD DEV

 

0.4690

 

% RSD

 

0.480

Intermediate precision

(Inter-Day)

Sample 1

302.6

7100521

97.84

Sample 2

302.5

7156223

98.64

Sample 3

302.9

7058621

97.17

Sample 4

302.1

7110532

98.14

Sample 5

301.9

7125368

98.41

Sample 6

302.4

7112539

98.07

 

Mean

 

98.05

 

STD DEV

 

0.5108

 

% RSD

 

0.521

Repeatability

Plus Inter-day

 

Mean

 

97.892

 

STD DEV

 

0.4942

 

% RSD

 

0.505

 

Chromatograms:  

 

 

Fig. Typical chromatogram of Repeatability precision (Sample 1)

Fig. Typical chromatogram of Inter-day precision (Sample 1)

 

Acceptance criteria:   

% Assay: % Assay value for each sample (Individual sample) and mean assay value for precision (6 samples), mean assay value intermediate precision (6 samples), and mean assay value for precision plus intermediate precision sample (12 samples): 90-110%  

% RSD: % RSD for precision study samples (6 samples), Intermediate precision study samples (6 samples) and precision plus intermediate precision sample (12 samples): NMT 2.0  Data interpretation: 

% Assay and % RSD was found well within acceptance limit and hence method is precise (Reproducible).  

 ROBUSTNESS:  

The robustness of an analytical method is a measure of its capacity to remain unaffected by small but deliberate variations in method parameters and provides an indication of its reliability during normal usage.  

 

Table. Result of Robustness study:

Change in Parameter

R.T.

Standard

area

Asymmetry

Theoretical plates

Wavelength by +3 NM (234 NM)

2.63

7080253

1.33

6312

Wavelength by -3 NM (230NM)

2.63

6893238

1.32

6085

Flow rate by +10% (1.1mL/min)

2.40

6520125

1.37

5953

Flow rate by -10% (0.9mL/min)

2.92

7953201

1.36

6742

Column oven temp by +2ºC (42 ºC)

2.63

7210539

1.31

5928

Column oven temp by -2ºC (38 ºC)

2.64

7256861

1.32

6082

 

Chromatograms:   

 

 

Fig. Typical chromatogram of Standard +2 NM

 

 

Fig. Typical chromatogram of Standard -2 NM  C.

Change in Flow rate by + 10% (1.1 mL/min)

 

 

Fig. Typical chromatogram of Standard +10% F.R.

D.        Change in Flow rate by - 10% (0.9 mL/min)

 

 

Fig. Typical chromatogram of Standard -10% F.R.

E.         Change in Column Oven temperature by +2°C:

Fig. Typical chromatogram of Standard +2°C C.O.T.

F.         Change in Column Oven temperature by -2°C:

 

 

Fig. Typical chromatogram of Standard -2ºC C.O.T.

 

Acceptance criteria:  

Chromatography (System suitability) acceptance criteria should not get failed.  

Data interpretation: From the above results, it was concluded that the system suitability test results was found well within the limit 

DISCUSSION 

The present RP-HPLC method was developed successfully for the estimation of Desidustat in solid dosage form. The selected column and mobile phase combination produced a sharp peak with a short retention time, which is advantageous for routine analysis. The use of Acetonitrile:Water (75:25, v/v) under isocratic conditions simplified the procedure and reduced analysis time.  

The method showed excellent linearity over the selected concentration range, confirming that detector response was directly proportional to analyte concentration. The low %RSD values obtained in precision studies demonstrate that the method is reliable and reproducible. Accuracy values within acceptable recovery limits further support the suitability of the method for quantitative analysis.  

Specificity testing confirmed that excipients and blank samples did not interfere with the analyte peak, which is important for tablet formulation analysis. Robustness studies showed that minor variations in analytical parameters did not significantly affect the results, indicating that the method is rugged enough for routine laboratory use.   Overall, the method is simple, economical, and suitable for routine quality control analysis of Desidustat tablets in pharmaceutical laboratories.  

CONCLUSION 

A rapid, accurate, precise, and validated RP-HPLC method was successfully developed for the estimation of Desidustat in solid dosage form. The method complies with ICH Q2(R1) requirements and demonstrated excellent linearity, precision, accuracy, specificity, and robustness. Because of its simplicity and reproducibility, the method is suitable for routine analysis of Desidustat in pharmaceutical quality control laboratories.  

REFERENCES 

  1. Gupta V, Jain ADK, Gill NS, Gupta K. Development and validation of HPLC method – A review. International Research Journal of Pharmaceutical and Applied Sciences. 2012;2(4):17–25.  
  2. Kazakevich Y, Lobrutto R. HPLC for pharmaceutical scientists. John Wiley & Sons; 2007.  
  3. Ahuja H, Rasmussen H. Development for pharmaceuticals. Elsevier; 2007.  
  4. Azim MS, Mitra M, Bhasin PS. HPLC method development and validation: A review. International Research Journal of Pharmacy. 2013;4(4):39–46.  
  5. Rao BV, Sowjanya GN, Ajitha A, Rao VUM. Review on stability indicating HPLC method development. World Journal of Pharmacy and Pharmaceutical Sciences. 2015;4(8):405–423.  
  6. Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. 3rd ed. Wiley; 2010.  
  7. ICH. Q2(R1): Validation of analytical procedures: Text and methodology. International Conference on Harmonisation; 2005.  
  8. Pandya R, Kachhiya H, Solanki K, Tandel J, Chhalotiya U, Shah D. RP-HPLC-PDA method development and validation for quantification of Desidustat. Journal of Chemical Metrology. 2023;17(2):215–224.  
  9. Prajapati JM, Patel S, Marvaniya V, Bhatt C. Stability indicating RP-HPLC method development and validation for the analysis of Desidustat in tablet dosage form. International Journal of Novel Research and Development. 2023;8(6):b55–b73.  
  10. Naazneen S. A validated RP-HPLC method for the determination of Desidustat in pharmaceutical dosage form. International Journal of Innovative Research in Technology. 2023;10(5):142–147.  
  11. Lanjewar A, Patidar D. RP-HPLC method for development, validation and assay of Desidustat in pharmaceutical formulation. International Journal of Innovative Research in Technology. 2024;11(3):1685– 1698.  

Dighe RD, Deore GS, Sonawane GB, Bairagi VA. Development and validation of stability indicating RPHPLC method for estimation of Desidustat in bulk drug and formulation. African Journal of Biological Sciences. 2024;6(11):326–344

Reference

  1. Gupta V, Jain ADK, Gill NS, Gupta K. Development and validation of HPLC method – A review. International Research Journal of Pharmaceutical and Applied Sciences. 2012;2(4):17–25.  
  2. Kazakevich Y, Lobrutto R. HPLC for pharmaceutical scientists. John Wiley & Sons; 2007.  
  3. Ahuja H, Rasmussen H. Development for pharmaceuticals. Elsevier; 2007.  
  4. Azim MS, Mitra M, Bhasin PS. HPLC method development and validation: A review. International Research Journal of Pharmacy. 2013;4(4):39–46.  
  5. Rao BV, Sowjanya GN, Ajitha A, Rao VUM. Review on stability indicating HPLC method development. World Journal of Pharmacy and Pharmaceutical Sciences. 2015;4(8):405–423.  
  6. Snyder LR, Kirkland JJ, Dolan JW. Introduction to modern liquid chromatography. 3rd ed. Wiley; 2010.  
  7. ICH. Q2(R1): Validation of analytical procedures: Text and methodology. International Conference on Harmonisation; 2005.  
  8. Pandya R, Kachhiya H, Solanki K, Tandel J, Chhalotiya U, Shah D. RP-HPLC-PDA method development and validation for quantification of Desidustat. Journal of Chemical Metrology. 2023;17(2):215–224.  
  9. Prajapati JM, Patel S, Marvaniya V, Bhatt C. Stability indicating RP-HPLC method development and validation for the analysis of Desidustat in tablet dosage form. International Journal of Novel Research and Development. 2023;8(6):b55–b73.  
  10. Naazneen S. A validated RP-HPLC method for the determination of Desidustat in pharmaceutical dosage form. International Journal of Innovative Research in Technology. 2023;10(5):142–147.  
  11. Lanjewar A, Patidar D. RP-HPLC method for development, validation and assay of Desidustat in pharmaceutical formulation. International Journal of Innovative Research in Technology. 2024;11(3):1685– 1698.  
  12. Dighe RD, Deore GS, Sonawane GB, Bairagi VA. Development and validation of stability indicating RPHPLC method for estimation of Desidustat in bulk drug and formulation. African Journal of Biological Sciences. 2024;6(11):326–344. 

Photo
Amol Pawase
Corresponding author

Department of pharmacognocy, Matoshri College of Pharmacy, Eklhare Nashik

Photo
Varsha Chaudhari
Co-author

Department of pharmacognocy, Matoshri College of Pharmacy, Eklhare Nashik

Amol Pawase, Varsha Chaudhari, Method Development and Validation of Desidustat in Solid Dosage Form by RP-HPLC Method, Int. J. of Pharm. Sci., 2026, Vol 4, Issue 8, 1612-1634, https://doi.org/10.5281/zenodo.21870367

More related articles
Nyctanthes arbor-tristis leaves extract improves t...
Shital Doifode, Dnyaneshwar Bomnale, Deepti Bandawane...
Method Development and Validation of Capmatinib in...
Prasad Bodake, Prashant Malpure, Varsha Chaudhari...
A Skin Revitalizing Herbal Facial Toner with Lotus...
Shradha Jadhav, Anju K. P, Antony Rinal, Bharath S, Deepak Singh ...
Development And Validation of Analytical Methods for Estimation of Calcium Chann...
Pradumn Pratap Singh , Pradeep Srivastava, Mahzbee Bano, Chanchal Gupta, Aman Amrit Raj...
Formulation And Evaluation of Anti Acne Gel...
Mohammad Altamash, Abdullah Danish, Khan Furkhan, Khan Mohd Saqlain, Kaif Kazi...
Formulation and evaluation of Herbal cream containing Achyanthes aspera extract ...
Narayane Ganesh , Dr. V. Tegeli, Kumbhar Bhaganna , Alamad Abhishek , Mali Nikita ...
Related Articles
Phytochemistry, Pharmacological Insights and Therapeutic Potential of Kalanchoe ...
Dr. Nidhi khatri, Bhanu Pratap Singh, Kunal deep Prajapat, Rahul Kumar Kumawat...
Drug-Induced Pancytopenia in Behcet's Disease with Coexisting Scrub Typhus Infec...
Alfeena N, Shaiju Dharan, Jim Litton, Grace Raju, Renjitha M S...
A Comprehensive Review on Herbal Hair Serum: Formulation and Evaluation Approach...
E. Hemalatha, A. Senthil, N. Sushmitha, R. Ramya, M. Mahalakshmi, V. Kathirnila...
Artificial Intelligence and Predictive Analytics: Transforming Recruitment Strat...
Devesh Bhavsar, Gitanjali Patil, Chhaya Mahajan, Pragati Patil...
Nyctanthes arbor-tristis leaves extract improves the hepatic damage in non-alcoh...
Shital Doifode, Dnyaneshwar Bomnale, Deepti Bandawane...
More related articles
Nyctanthes arbor-tristis leaves extract improves the hepatic damage in non-alcoh...
Shital Doifode, Dnyaneshwar Bomnale, Deepti Bandawane...
A Skin Revitalizing Herbal Facial Toner with Lotus Petals and Neem Leaves...
Shradha Jadhav, Anju K. P, Antony Rinal, Bharath S, Deepak Singh H...
Nyctanthes arbor-tristis leaves extract improves the hepatic damage in non-alcoh...
Shital Doifode, Dnyaneshwar Bomnale, Deepti Bandawane...
A Skin Revitalizing Herbal Facial Toner with Lotus Petals and Neem Leaves...
Shradha Jadhav, Anju K. P, Antony Rinal, Bharath S, Deepak Singh H...